skip to main content

Physicians and the pharmaceutical industry (update 2001)

Canadian Medical Association

Canadian Medical Association journal (CMAJ), 2001-05, Vol.164 (9), p.1339-1344 [Periódico revisado por pares]

Canada: CMA Impact, Inc

Texto completo disponível

Citações Citado por
  • Título:
    Physicians and the pharmaceutical industry (update 2001)
  • Autor: Canadian Medical Association
  • Assuntos: Bioethics ; Biomedical Research ; Clinical Trials as Topic - statistics & numerical data ; Drug Industry ; Education, Medical, Continuing - standards ; Ethics, Medical ; Humans ; Interprofessional Relations ; Organizational Policy ; Patient Advocacy ; Pharmaceutical industry ; Physician relations ; Physician's Role ; Research Support as Topic - standards ; Societies, Medical
  • É parte de: Canadian Medical Association journal (CMAJ), 2001-05, Vol.164 (9), p.1339-1344
  • Notas: ObjectType-Article-2
    SourceType-Scholarly Journals-1
    ObjectType-Instructional Material/Guideline-1
    ObjectType-Feature-3
    content type line 23
  • Descrição: The history of health care delivery in Canada has been marked by collaboration between physicians and the pharmaceutical and health supply industries; this collaboration extends to research as well as to education. Because medicine is a self-governing profession, physicians have a responsibility to ensure that their participation in such collaborative efforts is in keeping with their duties to their patients and society. The following guidelines have been developed by the CMA to assist physicians in determining when a relationship with industry is appropriate. Although directed primarily to individual physicians, including residents, and medical students, the guidelines also apply to relationships between industry and medical organizations. These guidelines focus on the pharmaceutical companies; however, the CMA considers that the same principles apply to relationships between physicians and all commercial organizations, including manufacturers and suppliers of medical devices, infant formulas, health care products and informatics, and other service suppliers. These guidelines reflect a national consensus of medical organizations and are meant to serve as an educational resource for physicians throughout Canada. 24. Travel and accommodation arrangements, social events and venues for industry-sponsored CME/CPD activities should be in keeping with the arrangements that would normally be made without industry sponsorship. For example, the industry sponsor should not pay for travel or lodging costs or for other personal expenses of physicians attending a CME/CPD event. Subsidies for hospitality should not be accepted outside of modest meals or social events that are held as part of a conference or meeting. However, faculty at CME/CPD events may accept reasonable honoraria and reimbursement for travel, lodging and meal expenses. Scholarships or other special funds to permit medical students, residents and fellows to attend educational events are permissible as long as the selection of recipients of these funds is made by their academic institution. *Peer selling occurs when a pharmaceutical or medical device manufacturer or service provider directly or through a third party sponsors a seminar or similar event that focuses on its own products and is designed to enhance the sale of those products. The company directly or through a third party engages a physician to conduct the session: this form of participation would reasonably be seen as being in contravention of the CMA's Code of Ethics, which prohibits endorsement of a specific product. Peer selling, as understood in this sense, differs from the sort of situation in which a pharmaceutical or medical device manufacturer or service provider provides funds to CME/CPD organizers to sponsor a bona fide educational event on a specific condition or on a specific product or service. In the latter event the control and structure of the CME/CPD event lies in the hands of the CME/CPD organizers. Even though the product or service may be the focus of such a bona fide event the arm's-- length nature of the sponsorship by the manufacturer and the fact that the control and structure of the event lie in the hands of the CME/CPD organizers remove it from the realm of advertising and the event does not constitute an endorsement of the product or service in question.
  • Editor: Canada: CMA Impact, Inc
  • Idioma: Inglês;Francês

Buscando em bases de dados remotas. Favor aguardar.